|
GATAD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.74450478904487E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.51390002942765E-09 |
| Normal-vs-Stage2 |
1.663970E-03 |
| Normal-vs-Stage3 |
1.160400E-04 |
| Normal-vs-Stage4 |
1.809410E-04 |
| Stage1-vs-Stage2 |
6.314600E-01 |
| Stage1-vs-Stage3 |
6.211200E-01 |
| Stage1-vs-Stage4 |
5.592200E-01 |
| Stage2-vs-Stage3 |
4.305200E-01 |
| Stage2-vs-Stage4 |
9.879000E-01 |
| Stage3-vs-Stage4 |
3.713800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.953000149437E-10 |
| Normal-vs-AfricanAmerican |
8.433900E-04 |
| Normal-vs-Asian |
5.469800E-02 |
| Caucasian-vs-AfricanAmerican |
4.235600E-01 |
| Caucasian-vs-Asian |
1.520590E-01 |
| AfricanAmerican-vs-Asian |
1.283790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.48359996404923E-09 |
| Normal-vs-Female |
4.26549999765768E-08 |
| Male-vs-Female |
9.226400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.435600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.20329998690261E-09 |
| Normal-vs-Age(61-80Yrs) |
2.87039999991023E-07 |
| Normal-vs-Age(81-100Yrs) |
9.110300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.837600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.526400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.227800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.866200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.979400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.643800E-03 |
| Normal-vs-Grade 2 |
1.289599982357E-09 |
| Normal-vs-Grade 3 |
5.42650000046052E-07 |
| Normal-vs-Grade 4 |
1.131540E-02 |
| Grade 1-vs-Grade 2 |
5.822800E-01 |
| Grade 1-vs-Grade 3 |
3.177600E-01 |
| Grade 1-vs-Grade 4 |
1.881230E-01 |
| Grade 2-vs-Grade 3 |
1.440020E-01 |
| Grade 2-vs-Grade 4 |
2.025200E-01 |
| Grade 3-vs-Grade 4 |
7.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.1306001407595E-10 |
| Normal-vs-ccB subtype |
1.79460999999437E-05 |
| ccA subtype-vs-ccB subtype |
2.181000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00649999446034E-09 |
| Normal-vs-N1 |
2.405200E-01 |
| N0-vs-N1 |
3.717400E-01 |
|
|
